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Summary
Objective: The objective of the study was to assess the risk of co-infections with human
immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis among
patients attending sexually transmitted disease (STD) clinics, antenatal clinics (ANC) and Ob-Gyn
outpatients department (OPD) clinics which were part of the sentinel surveillance program.
Methods: A serological screening was carried out during the period August—November 2002 to
assess the risk of infection with HIV-1/2, and co-infection with HBV, HCV, and syphilis among the
outpatients attending STD clinics, Ob-Gyn OPD clinics, and ANC of three district hospitals (Agra,
Etawah, and Farrukhabad) of Uttar Pradesh state in Northern India. Unlinked and coded serum
samples received from 863 patients (635 females and 228 males) were screened by laboratory
tests commonly used for laboratory diagnosis of HIV, HBV, HCV, and syphilis.
Results: Among the 863 samples serological reactivity was detected for HIV-1/2 in 21 (2.4%), HBV
in 25 (2.9%), HCV in nine (1.0%), and syphilis in 47 (5.4%). The incidence of HBV was higher among
males than females, i.e. 10/228 (4.4%) versus 15/635 (2.4%). Co-infection was observed for HIV—
HBV in two (0.2%), HBV—HCV in one (0.1%), and HIV—syphilis in one (0.1%). None were found to
have co-infection with HIV—HCV, HBV—syphilis, and HCV—syphilis. Age, sex, literacy level,
occupation, locality, migration, and presence of different sexually transmitted infections did
not significantly influence the rate of HIV positives.
Conclusion: A substantial percentage of the outpatients seen in the clinics of the district hospital
in Uttar Pradesh harbor HIV and viral hepatitis infections, which otherwise would remain
undiagnosed without serological screening.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +91 562 2331751x287; fax: 91 562 2331755.
E-mail address: tahziba_hussain@hotmail.com (T. Hussain).
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Among the blood-borne viruses transmissible through the
parenteral route, by blood transfusion, as well as by sexual
intercourse, human immunodeficiency viruses (HIV-1/2),
hepatitis B virus (HBV) and hepatitis C virus (HCV) are
important and have several implications. Not only do
they establish asymptomatic persistent infections with
occasional sequelae, but they also cause significant
morbidity and mortality when transmitted through transfu-
sion of blood and blood products.1 Chronic infections
with HIV, HBV, and HCV are major public health problems.
Many risk behaviors as well as the routes of transmission
for HBV and HCV infection are identical to those for HIV
and other sexually transmitted diseases (STDs). Early
diagnosis and effective treatment of STDs, especially
those that cause ulcers and blood-borne infections,
are an important strategy for the prevention of HIV
transmission.
Globally, the HIV sentinel surveillance system has been
recognized as an optimal mechanism to monitor trends of
HIV infection in specific high-risk groups as well as low-risk
groups. In India, high-risk populations include patients
attending STD clinics, men who have sex with men (MSM)
clinics, and drug addiction centers, while mothers attending
antenatal clinics are regarded as a proxy for the general
population.
This study was carried out at the Voluntary Confidential,
Counselling & Testing Centre (VCCTC) at the Central JALMA
Institute for Leprosy & Other Mycobacterial Diseases, Agra,
India. The objective of the study was to assess the risk of co-
infections with HIV, HBV, HCV, and syphilis among patients
attending the STD, ANC and Ob-Gyn OPD clinics who were
part of the sentinel surveillance program.
Screening for HIV, HBV, HCV, and syphilis was carried out in
order to determine the prevalence levels of these infections,
as biological markers of risk, modes, and time functions of
their transmission.
Study design
The study design, developed according to the guidelines
and operational procedures for sentinel surveillance, and
the method of testing, i.e., unlinked anonymous testing,
were formulated by the National AIDS Control Organization
(NACO) of the Government of India. The study was carried
out over a period of 4 months, between August and November
2002. The sample size and sampling period were decided at
the beginning of sentinel surveillance.
The sentinel sites were the outpatient department
(OPD) of STD clinics, Ob-Gyn OPD clinics, antenatal clinics
(ANC), and intervention clinics of different district hospi-
tals (Agra, Etawah, and Farrukhabad) of Uttar Pradesh,
India. The rationale for choosing sentinel sites in these
clinics was that the samples from the respective risk
groups attending the clinic-based settings could be col-
lected at regular intervals. Sites with 75% coverage of
desired sample size were included for analysis. The ratio-
nale for the choice of sample size for the various groups
(STD clinic and Ob-Gyn OPD attendees, are considered to
be high-risk groups whereas ANC clinic attendees are alow-risk group) was that during this 4-month period,
approximately 900 samples could be collected conveni-
ently. The target was to test 900 samples but due to
operational difficulties, this was not achieved by the
end of the sampling period.
The inclusion criterion for ANC cases was all antenatal
women attending the ANC clinic for the first time during the
sampling period. Criteria for STD patients were male
patients presenting with genital ulcer/warts/urethral dis-
charge and female patients presenting with genital ulcer/
warts/cervical discharge as confirmed by per speculum
examination. Criteria for Ob-Gyn OPD patients were new
STD patients attending Ob-Gyn OPD during the sampling
period and patients attending the intervention clinics, with
or without symptoms.2
The whole procedure was unlinked and anonymous. Thus,
unlinked anonymous coded sera samples received from 863
patients were screened simultaneously for co-existing infec-
tions with HIV, HBV, HCV, and syphilis.
Materials and methods
Sampling technique
The sampling of STD/ANC clinic and Ob-Gyn OPD and inter-
vention clinic attendees was commenced at the beginning
of the sampling period, i.e., 1 August 2002, and continued
until the end of November 2002. Blood samples (5 mL) were
drawn at the respective clinic sites to avoid dropouts.
Consecutive blood samples were collected aseptically from
each survey participant, i.e., 250 new STD patients (150
from the STD clinics and 100 from the Ob-Gyn OPD of Agra),
400 antenatal cases attending the ANC clinic of Etawah, and
250 clinic attendees for syphilis and HIV testing (150 from
the STD clinics and 100 from the Ob-Gyn OPD of Farrukha-
bad). The procedure was to continue consecutive sampling
until the pre-determined sample size was reached or the
pre-determined sampling period was over. Due to opera-
tional difficulties the pre-determined sample size was not
reached, however this study was completed using the num-
ber of samples actually collected even though less than
anticipated. The serum samples, collected after centrifu-
gation at 2500 g, were delivered to our laboratory under
strict cold chain precautions. These samples were stored at
20 8C until assays were performed.
Method of testing
Unlinked anonymous testing means that the sample was
originally collected for another purpose, so, for example,
a sample collected for syphilis diagnosis is tested for HIVafter
all information that could identify the source of the blood
sample has been eliminated from the sample.
ELISAwas carried out for HIV detection using Genedia HIV-
1/2 EIA kit (Greencross, Korea). Those found positive were
confirmed by rapid (HIV capillus latex aggregation assay,
Trinity Biotech plc, Ireland) and rapid spot assays (Genelabs
Diagnostics Pte. Ltd, Singapore).
The samples were further tested by HBV kit-HEPALISA
(Microwell ELISA test for the detection of hepatitis B surface
antigen (HBsAg) in human serum/plasma, J. Mitra & Co. Ltd,
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noassay for the detection of hepatitis C virus (anti-HCV) in
human serum/plasma (LG Chemical Ltd, Seoul, Korea), and
VDRL-CARBOGEN rapid plasma reagin (RPR) card test/carbon
antigen for syphilis testing (Tulip Diagnostics (P) Ltd, Goa,
India). Serum samples were diluted and tested according to
the kit’s specifications.
Statistical analysis
Data were analyzed to determine the statistical significance
of the association between HIV status and sex, age, locality,
literacy, occupation, period of stay, and history of STDs
of the attendees using Pearson’s Chi-square test. The sig-
nificance of the difference in the proportion of HIV positives
among the different categories was also examined with
Z statistics at 5% level of significance.
Results
The results of 863 samples received from different sentinel
sites of district hospitals of Uttar Pradesh, which were
screened for HIV and other co-infections are shown in
Tables 1—3.Table 1 The socio-demographic characteristics, HIV status and h
STD patients (n = 863) Male (n
Parameters Categories No.
Age group (years) <20 32
21—29 109
30—44 69
>45 18
Locality Urban 126
Rural 102
Literacy status Illiterate 53
Literate and to 5th grade 32
To 12th grade 83
Graduate and above 60
Occupation Agriculture/unskilled worker 83
Truck/taxi/auto drivers/Cleaners 11
Industrial workers 5
Hotel staff 7
Service staff 43
Business and commerce 40
Unemployed 9
Student 30
Housewife 0
Migration Migrant 14
Non-migrant 214
STD Genital ulcers 90
Urethral discharge 105
Genital ulcers and urethral/
cervical discharge
15
Cervical discharge 0
Genital warts 18Table 1 shows the socio-demographic characteristics, HIV
status, and history of STDs among patients attending the STD
clinics. Of the 863 patients, 16 (2.5%) females and five (2.2%)
males were infected with HIV. Among the outpatient clinics,
13 (2.6%) patients in the 21—29 years age group and seven
(2.6%) in the 30—44 years age group were HIV positive. Their
marital status was not defined. The difference in HIV positive
status was not significant ( p = 0.321) between urban and
rural areas (12 (3.0%) in urban and nine (1.9%) in rural areas).
Ten of the 358 (2.8%) illiterate patients were HIV positive.
Further, among the 125 (14.5%) clinic attendees who were
graduates, four (3.2%) were HIV positive.
Laborers, mainly migrants, were those most frequently
infected with HIV and had the maximum number of STDs.
Among the 863 patients were agricultural and unskilled work-
ers, housewives, business and commercial workers, service
staff, students, industrial workers, unemployed, drivers and
hotel staff. Among these groups, the percentage of HIV posi-
tives was highest in unemployed males (4.2%). The difference
in percentages of HIV positivity in the various occupational
groups of females was found not to be statistically significant.
Those who had stayed in one place for more than 6 months
were regarded as non-migrants. Among 814 non-migrants, 20
(2.5%) were HIV positive. Among migrants 1/49 (2.0%) wasistory of STDs among patients attending the outpatient clinics
= 228) Female
(n = 635)
Total (n = 863) Statistics
HIV pos No. HIV pos No. HIV pos p value
1 32 0 64 1 p = 0. 818
2 391 11 500 13
2 204 5 273 7
0 8 0 26 0
3 275 9 401 12 p = 0.321
2 360 7 462 9
2 305 8 358 10
0 102 1 134 1 p = 0.550
3 163 3 246 6
0 65 4 125 4
3 204 8 287 11
0 0 0 11 0 p = 0.692
0 22 0 27 0
0 1 0 8 0
0 58 1 101 1
0 80 2 120 2
1 15 0 24 1
1 47 1 77 2
0 208 4 208 4
0 35 1 49 1 p = 0.623
10 600 10 814 20
2 35 2 125 4
3 0 0 105 3
0 10 0 25 0 p = 0.617
0 187 2 187 2
0 403 12 421 12
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Table 2 HIV, HBV, HCV, and syphilis status of patients attending the STD, ANC, Ob-Gyn OPD Clinics
STD patients Male (n = 228) Female (n = 635) Total number of patients
screened (n = 863)
HIV status Reactive 5 (2.2%) 16 (2.5%) 21 (2.4%)
Non-reactive 222 (97.4%) 619 (97.5%) 842 (97.6%)
HBV status Reactive 10 (4.4%) 15 (2.4%) 25 (2.9%)
Non-reactive 218 (95.6%) 620 (97.6%) 838 (97.1%)
HCV status Reactive 2 (0.9%) 7 (1.1%) 9 (1.0%)
Non-reactive 226 (99.1%) 628 (99.0%) 854 (98.9%)
Syphilis status Reactive 10 (4.4%) 37 (5.8%) 47 (5.4%)
Non-reactive 218 (95.6%) 598 (94.2%) 816 (94.6%)
Table 3 HIV, HBV, HCV, and syphilis status of the STD, Ob-Gyn OPD and ANC clinic attendees
Sentinel sites Samples screened HIV positive HBV positive HCV positive Syphilis positive
STD clinic, Agra 150 5 (3.3%) 6 (4%) 2 (1.3%) 8 (5.3%)
Ob-Gyn OPD, Agra 100 — 1 (1%) 2 (2%) 3 (3%)
STD clinic, Farrukhabad 135 3 (2.2%) 6 (4.4%) 2 (1.5%) 6 (4.4%)
Ob-Gyn OPD, Farrukhabad 78 1 (1.3%) — — 4 (5.1%)
ANC clinic, Etawah 400 12 (3%) 12 (3%) 3 (0.8%) 26 (6.5%)
Total 863 21 (2.4%) 25 (2.9%) 9 (1.0%) 47 (5.4%)HIV positive of which none were male; 1/35 (2.9%) of migrant
females was HIV positive.
The chief presenting symptoms among the 863 patients
at the time of visit to the clinic were genital warts, genital
ulcers, urethral discharge and cervical discharge. HIV posi-
tivity occurred in 4/125 (3.2%) clients with genital ulcers,
3/105 (2.9%) with urethral discharge, 2/125 (1.6%) with
genital ulcers and urethral/cervical discharge, 4/287
(1.4%) with cervical discharge and 8/221 with genital warts.
Genital ulcers and warts are very important since the risk
of acquiring HIV infection associated with STDs increases
in their presence.
Of 863 patients, 21 (2.4%) were HIV positive and 47 (5.4%)
were syphilis reactive. This suggests that STDs affect a large
percentage of clinic patients.
The results revealed that none of the variables — sex, age,
literacy status, occupation, locality, migration, and even the
presence of different STDs — were found to significantly
influence HIV positivity.
Table 2 shows that of the 863 patients, 21 (2.4%) STD, ANC
and Ob-Gyn OPD clinic attendees were HIV positive, 25
(2.9%) were positive for hepatitis B virus by both rapid assays
and ELISA, nine (1.0%) were positive for antibodies to the
hepatitis C virus by ELISA, and 47 (5.4%) had antibodies to
syphilis (reactive for syphilis by the simple RPR card test).
More males (10 (4.4%)) than females (15 (2.4%)) had HBV.
Table 3 shows the HIV, HBV, HCV, and syphilis status of the
STD, Ob-Gyn OPD and ANC clinic attendees. HIV positivity
ranged from 1 to 3% among the clinic attendees, 1 to 4% for
HBV, 0.8 to 2% for HCV and 3 to 6% for syphilis.
No HIV positivity was reported from the Ob-Gyn OPD
clinic in Agra. No positivity for HBV or HCV infection
was reported from the Ob-Gyn OPD clinic in Farrukhabad.
Attendees of the ANC clinic in Etawah had positivity at 3%each for HIV and HBV, 0.8% for HCV and 6.5% for syphilis
reactivity. This is of serious concern as ANC cases were
considered to be the low-risk group.
Discussion
Sexually transmitted diseases (STDs) remain a public health
problem of major significance in most parts of the world.3—5
The incidence of acute STDs is high in many countries,
including India although the precise magnitude of the
problem is still not clear.6—8 Failure to diagnose and treat
STDs at an early stage results in serious complications and
sequelae, including infertility, fetal wastage, ectopic preg-
nancy, cancer, and death.9 The explanation for the increase
in STDs is multifactorial, heterosexual promiscuity being
one of them.10
Analysis of our results revealed that none of the variables
— sex, age, literacy status, occupation, locality, migration,
and even the presence of different STDs — significantly
influenced the rate of HIV positivity among the attendees
of the STD clinics. More males, i.e., 10 (4.4%) had HBV than
females, 15 (2.4%). With regard to HCV (7/635) and syphilis
(37/635), females were more affected than males but this
could be due to the larger number of females, 635 as
compared to 228 males screened during the surveillance.
There were co-infections: two (0.2%) with HIV—HBV, one
(0.1%) HBV—HCV, and nine (1.0%) with HIV—syphilis infec-
tions. Although the percentage of patients with co-infec-
tions is lower, the combination of viral infections such as HIV
and HBV or HBV and HCV is a dangerous co-existence11—13
and may have a detrimental effect on the patient and the
treatment outcome. None were found to be co-infected
with HIV—HCV, HBV—syphilis, or HCV—syphilis.
362 T. Hussain et al.The results reveal that patients attending the STD,
Ob-Gyn OPD, and ANC clinics harbor blood-borne viral infec-
tions like HIV, HBV, and HCV, which would otherwise remain
undiagnosed in the absence of screening. Further, they are
unaware of the underlying co-infection because this was an
unlinked anonymous testing of coded samples.
Many studies showing the varying rates of HIV and HCV
infections among STD patients have been reported by sev-
eral authors in India and abroad. Kaur and Marshalla
screened 233 serum samples for HIV, HBV, HCV, and syphilis
and found that 21% were positive for syphilis, 3% for HBsAg
and HIV-1 and 0.8% for HCV, and no correlation was observed
in the transmission of two or more pathogens.14 Garg et al.
evaluated 46 957 donors for HIV, HBV, HCV, and syphilis. Of
these, 90.1% were replacement donors and 9.0% were
voluntary donors and the incidence of HIV was 0.44%,
HBV was 3.44%, HCV was 0.29%, and VDRL was 0.22%.15
Nanu et al. screened 132 093 voluntary and replacement
donors and reported that HBsAg rates remained below 2.5%,
HIV 0.55%, syphilis 0.52%, and HCV 1.49% among donors, and
those with multiple infections were uncommon.16 Patel
screened 60 780 donors in Mumbai over a 6-year period,
from 1994 to 1999, and found that 0.78% had antibodies to
HCV, 0.26% had antibodies to HIV, and 1.7% had antibodies to
HbsAg.17 Gupta et al. screened 44 064 blood units in Ludhi-
ana, during the period 2001—2003 and reported 0.08% had
antibodies to HIV, 0.60% had antibodies to HBsAg, 0.11% had
antibodies to anti-HBc, 1.09% were HCV positive, and 0.85%
had antibodies to syphilis.18 Ruan et al. reported 71.0% of
the 379 intravenous drug abusers (IDAs) in China had anti-
bodies to HCVand 11.3% had antibodies to HIV. HCV—HIV co-
infection among IDAs was 11.3%.19 Taketa et al. screened 98
IDAs, 100 commercial sex workers (CSWs) and 50 males with
STDs in Thailand and reported that HCV is transmitted
primarily by blood contact, HIV primarily by blood contact
and secondarily by sexual contact, but HBV by both blood
and sexual contact.20 Galvin and Cohen reported that one in
every 1000 episodes of sexual intercourse leads to HIV
infection21 thereby suggesting slow efficiency of HIV spread.
Gordin et al. screened 616 patients in the USA and found
that 23 (3.7%) were HIV positive and 2.0% (12/612) were
positive for HbsAg.22 Segurado et al. screened HIV-infected
individuals in Brazil23 and reported that exposure to blood
and sexual partnership with IDUs constitute the main risk
factors for HCV acquisition among HIV-positive patients.
Choy et al. screened for HCV infection in STD-infected
patients24 in New Jersey, USA and reported that inner-city
obstetric patients are at high risk for HCV infection when
compared with the general population. Increasing age and
HIV positive status are the risk factors that are significantly
associated with HCV infection. In STD clinics, integrating
risk-based screening into routine clinic services is an effi-
cient way to identify HIV-infected persons.25—27 The
increased risk of HBV, HCV, and HIV infection among STD
patients warrants specific preventive action.28—30 HIV, HCV,
and HBVmay promote each other and be related to different
cultures and living habits31 though this does not appear to be
the case in our study population.
Screening the high-risk population for these viral infec-
tions would aid early detection of co-infections and hence
early treatment, which, if initiated, would help to decrease
the further spread of these blood-borne infections. There isa need, therefore, to support an approach of targeted
screening of all these viral infections, integrating viral hepa-
titis testing, counseling and referral services into the existing
STD prevention and treatment services.
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